You pull up your pharmacy's app to check the price of Ozempic or Wegovy, and the number on the screen doesn't look real. Without insurance, brand-name GLP-1 medications list for over $1,000 a month. That's not a typo, and it's exactly why so many people start looking for another way in.

The fastest way to get there is a Shed evaluation. Shed's providers can determine whether a brand-name GLP-1 is right for you and write the prescription that unlocks manufacturer self-pay pricing, often $199 to $499 a month instead of $1,000+, or, if appropriate, a documented-need compounded formulation. Start your Shed evaluation to see what you qualify for.

Here's the part that's changed recently: the cheapest legitimate way to get GLP-1 medications without insurance is now usually a manufacturer-run self-pay pharmacy program, not a compounding pharmacy. Compounded semaglutide and tirzepatide used to be the go-to budget option, but the rules around who can access them have tightened significantly. Below is how the pricing actually breaks down today, and why working with Shed is the most direct route to it.

Why Are GLP-1 Medications So Expensive Without Insurance?

Brand-name GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound carry list prices set by the manufacturer, not by your local pharmacy. Without a health plan negotiating a lower rate on your behalf, you're paying close to the full list price out of pocket, often $1,000 or more a month.

Insurance doesn't always help even if you have it. Plenty of health plans still treat weight loss medication as a lifestyle drug rather than a medical necessity, so coverage gets denied even when a doctor writes the prescription. That leaves a large number of patients paying full price regardless of whether they're insured.

Coverage rules are shifting too. Some Medicare and Medicaid proposals could eventually cover GLP-1s for weight loss, but for now, most people paying without insurance need a plan that works today, not a policy that might change next year. This is where a Shed evaluation matters most: it gets you a clear, current answer instead of waiting on policy that may never apply to you.

What Happened to Compounded GLP-1 Medications?

For a couple of years, compounded semaglutide and tirzepatide were the default answer to this question, and for good reason. The FDA allowed pharmacies to compound versions of these medications while Ozempic, Wegovy, Mounjaro, and Zepbound were on the national drug shortage list, which made a lower-cost option widely available.

That shortage is over. Tirzepatide came off the FDA's drug shortage list in late 2024, and semaglutide followed in early 2025. Once a drug is no longer in shortage, pharmacies lose the legal basis for compounding a copy of it just because it's cheaper or more convenient. According to the FDA, compounded versions are now only appropriate when a patient has a specific, documented clinical need that an FDA-approved product can't meet, such as an allergy to an inactive ingredient or a need for a dosage form that isn't commercially available. The FDA has also proposed removing semaglutide and tirzepatide from the list of substances outsourcing facilities can compound from at all, which would tighten things further.

In practice, this means compounded semaglutide or tirzepatide is no longer something you can request purely to save money. It's still a legitimate option for the specific patients who medically need it, including some who use formats like GLP-1 liquid drops when a standard injection isn't the right fit, but it isn't the broad budget workaround it was a couple of years ago. This is exactly the kind of judgment call that needs a licensed provider behind it, not a guess, which is why this determination is part of every Shed evaluation.

How Shed Gets You to the Cheapest Legitimate Price

For most people paying out of pocket today, the best pricing comes through manufacturer-run self-pay pharmacies: NovoCare Pharmacy for Ozempic and Wegovy, and the LillyDirect Self-Pay Pharmacy for Zepbound. These are the same FDA-approved medications, sold directly at a lower self-pay price instead of the full list price. But that pricing isn't self-serve; it requires a valid prescription from a licensed provider.

That's the role Shed plays. A Shed provider evaluates your history, confirms whether a brand-name GLP-1 fits your situation, and writes the prescription that opens up self-pay pricing through NovoCare or LillyDirect, or identifies whether a documented-need compounded option is more appropriate for you. You're not left to figure out the manufacturer programs on your own or track down a separate prescriber first.

Now limited to documented clinical necessity, not a general budget option; a Shed provider can confirm if you qualify

Wegovy and Ozempic's self-pay pricing comes from Novo Nordisk's own pharmacy program, and Zepbound's comes directly from Lilly. Mounjaro currently doesn't have an equivalent manufacturer self-pay option, which is why it tends to be the most expensive of the four without insurance.

How Does This Compare to a Couple of Years Ago?

It's a real shift. Compounded versions used to undercut these prices by a wide margin. Now that access to compounding is restricted, the manufacturer self-pay programs have actually become the more competitive, and more reliably legal, option for most people. It's also worth understanding how GLP-1 medications work in the first place, since the format and pricing model don't change how the medication behaves in your body.

• Same active ingredient, lower price: Self-pay programs sell the actual FDA-approved medication, not a compounded version.
• No shortage-related uncertainty: Because you're getting the approved product, supply and legality aren't in question.
• Pricing is usually published upfront: Both NovoCare and LillyDirect list their self-pay pricing directly on their sites. A Shed evaluation is what confirms which price applies to you and gets the prescription moving.

What About Manufacturer Savings Cards?

Separate from the self-pay pharmacy programs, Novo Nordisk and Eli Lilly also run traditional savings cards for Ozempic, Wegovy, Mounjaro, and Zepbound. The catch is that most of these cards are built for people who already have commercial insurance, even if that insurance doesn't cover the medication itself. If you have no insurance at all, a savings card usually won't apply, which is why the self-pay pharmacy programs, and getting a prescription for them through Shed, matter more for this specific question.

Is a Compounded GLP-1 Still an Option for You?

It can be, if you have a documented medical reason a commercially available product doesn't work for you. This isn't something to seek out purely for cost savings, since that's no longer how compounding is meant to be used for these medications. It's a determination a Shed provider can make with you directly, based on your history.

Questions a Shed Evaluation Answers Before You Start

Is this a compounded or FDA-approved medication? A Shed provider tells you exactly what you're being prescribed and why.

If compounded, what's the documented clinical reason? Cost alone is no longer a sufficient reason under current FDA guidance.

Is pricing clear upfront? Shed points you to a flat, published monthly price rather than vague savings claims.

Can you reach your care team later? Dosing often needs adjusting, so ongoing access to a provider matters more than the first prescription. That ongoing access is built into Shed's program.

Other Ways to Lower the Cost

A few smaller adjustments can help no matter which route you choose. Starting at a lower dose and titrating up slowly, as most providers already recommend for tolerability, also happens to cost less per month early on. Shed's providers can also talk through alternative options like metformin, naltrexone, and topiramate, since some patients respond well to non-GLP-1 medications at a fraction of the cost.

Pairing medication with health coaching can also shorten how long you need to stay on a higher dose, since building sustainable habits alongside treatment tends to support results rather than relying on the medication alone. Shed's programs build this coaching in alongside your prescription, so cost management isn't just about which pharmacy price you land on.

Can You Use an HSA or FSA to Pay for GLP-1 Medications?

Often, yes. If you have a Health Savings Account or Flexible Spending Account, GLP-1 medications prescribed for a diagnosed medical condition, including obesity or type 2 diabetes, typically qualify as an eligible expense. That applies whether you're paying list price, using a manufacturer self-pay program, or filling a compounded prescription for documented clinical need. It's worth checking with your HSA or FSA administrator directly, since some plans want a letter of medical necessity on file, especially for weight management prescriptions, which a Shed provider can supply if appropriate.

Using pre-tax HSA or FSA dollars effectively lowers your real cost further, on top of whatever self-pay pricing you access through Shed's evaluation. It's an easy detail to overlook, but it can meaningfully change the math over a full year of treatment.

What If You Have Type 2 Diabetes Instead of, or Alongside, Weight-Related Goals?

The cost conversation shifts a bit if your prescription is for blood sugar management rather than weight loss alone. Ozempic and Mounjaro are FDA-approved specifically for type 2 diabetes, and manufacturer patient assistance programs for diabetes medications have historically been broader and easier to qualify for than weight-loss-specific savings offers, particularly for patients who fall below certain income thresholds. If diabetes is part of your diagnosis, a Shed provider can flag the diabetes-focused assistance programs alongside the general self-pay pricing covered above, since you may qualify for both simultaneously.

A Word of Caution on Overseas or Gray-Market GLP-1 Sources

Given the price gap between list price and self-pay options, it's tempting to look at international pharmacies or unregulated online sellers claiming even lower prices. This is one area where the cheapest listed price can carry real risk. Medications sourced outside licensed U.S. pharmacy channels aren't guaranteed to be authentic, correctly dosed, or even the drug they claim to be, and there's no easy way to verify what you're actually receiving.

Working with Shed costs a bit more than an anonymous overseas seller, but it comes with a verifiable chain of custody, a real medical evaluation, and ongoing provider access, which matters enormously with an injectable medication.

Finding a Path That Works for Your Budget

Going without insurance doesn't mean going without options, it just means the cheapest legitimate path has changed. The most reliable way to reach it is still a real evaluation: Shed's clinical team can tell you honestly whether a self-pay brand-name option or a documented-need compounded formulation fits your situation, and write the prescription that gets you there, backed by coaching support so you're not paying for medication alone.

Start your Shed evaluation today to find out which path applies to you.

FAQs About Getting GLP-1 Without Insurance

How do I get GLP-1 without insurance?

Start with a Shed evaluation. A Shed provider can determine whether you qualify for manufacturer self-pay pricing (like NovoCare for Ozempic and Wegovy, or LillyDirect for Zepbound) or a documented-need compounded option, then write the prescription that unlocks it.

How much is GLP-1 without insurance?

Brand-name list prices run about $1,000 to $1,350 a month. Through manufacturer self-pay programs, which require a prescription from a provider like Shed, Wegovy, Ozempic, and Zepbound typically cost $199 to $499 a month depending on dose.

Is compounded semaglutide still available?

Yes, but only for patients with a specific, documented clinical reason a commercially available product doesn't work for them. A Shed provider can confirm whether you qualify. It's no longer available purely as a lower-cost alternative.

Do manufacturer savings cards work without insurance?

Traditional savings cards usually require existing commercial insurance. The separate self-pay pharmacy programs from Novo Nordisk and Lilly don't require insurance at all, but they do require a prescription, which a Shed evaluation provides.

Why did compounded GLP-1 prices and availability change?

Compounding was permitted while these medications were on the FDA's drug shortage list. Once semaglutide and tirzepatide came off that list in late 2024 and early 2025, the legal basis for broad compounding ended.

Can I use my HSA or FSA to pay for GLP-1 medications?

Usually yes, if the medication is prescribed for a diagnosed condition like obesity or type 2 diabetes. Check with your plan administrator, since some require a letter of medical necessity, which a Shed provider can supply.

Are GLP-1 medications cheaper for diabetes than for weight loss?

Sometimes. Patient assistance programs for diabetes-approved medications like Ozempic and Mounjaro have historically been broader than weight-loss-specific offers, so it's worth asking your Shed provider about both if your diagnosis qualifies.

Is it safe to buy GLP-1 medication from an overseas pharmacy?

It's risky. Medications from unlicensed or overseas sellers aren't guaranteed to be authentic or correctly dosed. Working with a provider like Shed costs more than a gray-market seller but guarantees you're getting the real, FDA-approved medication with a legitimate prescription behind it.

Disclaimer: This content is provided for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. You should consult a licensed healthcare provider for evaluation and guidance specific to your situation before starting or changing any treatment, supplement, or medication.

Ozempic®, Wegovy®, Zepbound®, and Mounjaro® are registered trademarks of their respective manufacturers. Shed is an administrative platform and is not affiliated with, endorsed by, or associated with these manufacturers.

Compounded medications are not FDA-approved for safety, effectiveness, or quality and are only appropriate for patients with a documented clinical need that an FDA-approved product cannot meet. They are prepared by a licensed pharmacy based on a provider's prescription. Pricing and availability may vary and change.

Shed is not a pharmacy and does not dispense medications. Prescriptions are fulfilled and shipped by a licensed third-party dispensing pharmacy.